NIRVA

Nirva Institute

Research Roadmap

How the Institute intends to develop Nervous System Intelligence from framework to field.

This is not a research prospectus. It is a public commitment to the sequence of work required to move NSI from a proposition into a discipline other researchers, clinicians, and educators can extend.

Phase 01 — Definition

  • Publish the founding NSI white paper (complete).
  • Establish official terminology and canonical definitions (in progress).
  • Articulate proposed models with clear scope, limitations, and testable predictions.
  • Distinguish established findings from Nirva Life’s synthesis and from proposed models.

Phase 02 — Collaboration

  • Invite comment and critique from neuroscience, psychology, medicine, behavioral science, education, and rehabilitation.
  • Establish an external scientific advisory circle.
  • Pursue two university research partnerships focused on measurable NSI applications.
  • Formalize institutional review and ethics oversight for any human-subjects work.

Phase 03 — Instrumentation

  • Refine the Framework Reflection as a research-grade reflective instrument.
  • Develop the anonymized experience dataset produced by I’mPossible™ as a novel scientific resource.
  • Publish methodology papers before publishing outcomes.

Phase 04 — Publication

  • Institute position papers on the core NSI concepts (Experience Loop, Invisible Patterns, Contextual Regulation, Nervous System Literacy).
  • Peer-reviewed empirical work in collaboration with university partners.
  • Open-access clinical and educational applications.

Phase 05 — Translation

  • Translate evidence into educational curricula (Nirva Academy).
  • Translate evidence into clinical decision-support (NirvaCare™).
  • Translate evidence into organizational literacy programs.

What we will not do

  • We will not claim clinical validation before it exists.
  • We will not brand NSI as a therapy or medical treatment.
  • We will not publish outcomes without publishing methods.
  • We will not collect sensitive health information through public marketing surfaces.